Darwin Bioprospecting Excellence — No stage disclosed

Repsol Corporate Venturing took a 21.43% stake in Valencian biotech Darwin Bioprospecting Excellence through a capital increase, with Valencian fund Biozell taking a minority position; the amount was not disclosed. Repsol also transferred to Darwin its technology for biodegrading polyethylene and polyurethane microplastics.

LeadRepsol Corporate Venturing RoundNo stage disclosed Announced6 Feb 2025 CityPaterna · reported Valencia SectorHealthtech & Bio · Biotech Source W

Something wrong? Suggest a correction →